| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
4,902 |
4,849 |
$246K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
5,256 |
4,479 |
$235K |
| 99205 |
Prolong outpt/office vis |
6,799 |
5,856 |
$105K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
2,825 |
2,484 |
$74K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
4,864 |
3,954 |
$55K |
| S9083 |
Global fee urgent care centers |
516 |
501 |
$17K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
2,743 |
1,815 |
$13K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
1,754 |
1,234 |
$11K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
881 |
856 |
$10K |
| 99000 |
|
3,314 |
2,449 |
$6K |
| 11043 |
|
224 |
94 |
$5K |
| 99051 |
|
2,203 |
2,149 |
$3K |
| A6250 |
Skin sealants, protectants, moisturizers, ointments, any type, any size |
899 |
454 |
$2K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
68 |
65 |
$2K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
667 |
660 |
$1K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
132 |
61 |
$1K |
| 99326 |
|
54 |
54 |
$1K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
19 |
17 |
$900.00 |
| 99334 |
|
126 |
66 |
$886.50 |
| 99335 |
|
84 |
71 |
$833.03 |
| 81003 |
|
675 |
658 |
$790.02 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
533 |
401 |
$563.75 |
| 86328 |
|
43 |
41 |
$461.38 |
| 81025 |
|
30 |
29 |
$287.77 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
29 |
29 |
$286.00 |
| A9150 |
Non-prescription drugs |
98 |
98 |
$107.00 |
| 81000 |
|
53 |
51 |
$100.10 |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
19 |
17 |
$100.00 |
| 36415 |
Collection of venous blood by venipuncture |
16 |
14 |
$98.00 |
| 81002 |
|
13 |
13 |
$4.26 |
| 99070 |
|
15 |
15 |
$0.00 |
| 36416 |
|
16 |
16 |
$0.00 |